Abstract
Introduction
Current practice amongst ENT surgeons in nasal airway assessment in the United Kingdom (UK) is unknown, and a UK study of nasal airway assessment practice has not been performed. Nasal obstruction is a highly prevalent complaint in clinical and ENT practice 1 , leading to approximately $5 billion per year in treatment costs in the USA. 2 The causes and sites of obstruction are numerous; accurate diagnosis is therefore essential for effective management. There is a patient dissatisfaction rate of 30% following surgery for nasal obstruction, and hence a growing need to improve our assessment of nasal patency. 3 Murrell performed a survey of USA practice in functional nasal airway assessment in 2013 4 and concluded that clinical history and nasal examination with anterior rhinoscopy were the two most universal parts of a functional assessment of nasal blockage. However, it was noted that they both proved challenging to measure as an outcome owing to their subjective interpretation. Hence, the author's recommendation was to additionally perform a symptom specific questionnaire in the form of the validated Nasal Obstruction and Symptom Evaluation (NOSE) scale, nasal endoscopy to exclude a posterior obstruction (noted to be present in 28% of cases), clinical response to nasal decongestants to indicate reversible inflammatory obstruction, as well as response to Breathe Right ® strips to exclude structural nasal valve obstruction.
The aim of our survey was to determine current practice in nasal patency assessment in the UK, and to assess areas for development and determine areas of further need.
Methods
Participants completed a written questionnaire, containing five domains: 3. Respondents who used at least one objective method in Part 2 were asked what they felt are the most important characteristics of these methods, and if and how they could be improved.
4. The respondents who did not report using any objective methods were asked why this was not the case.
5. The respondents were asked for the desirable attributes of a hypothetical new nasal blockage assessment device.
The setting for dissemination of the questionnaire was the British Academic Conference in Otolaryngology (BACO) 2015. Questionnaires were distributed amongst two of the BACO rhinology symposia where the lead author was presenting, with a delegate population of 250.
The questionnaires were left on the seat prior to the talks; the participants were then invited to complete them, for them to be collected afterwards. Although an international response was recorded, only UK responders were included. When asked what was used in order to diagnose nasal blockage, almost all respondents used the clinical history (97%) and physical examination (93%). 73% also used the nasal misting pattern on a metal spatula. The most commonly-used objective measurement device was the PNIF meter, which was utilised by 19% of the respondents. The most commonly-used subjective measurement questionnaire was the SNOT-22/23, with a 29% uptake ( Figure 1) .
Results
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When asked what was used in making the decision on whether to operate or not, as well as to assess the post-operative outcome, we found very similar answers were given, apart from the use of the nasal misting pattern, which decreased to 37%. 62 respondents commented on how they engaged in patient education: the most commonly-used method was also physical examination (65%), followed by patient history (58%), and 30% used nasal spatula misting.
When asked to rate the most important characteristics of an ideal objective assessment tool; accuracy scored the highest, with 19.5% on the points-based system used, followed by ease of operation (16.6% of points). Portability was the least important (3.2%), with the remaining options assigned a similar level of importance by the respondents.
Using a Likert scale, 38 of 42 respondents (90%) either agreed, or strongly agreed, that the existing objective methods for quantifying nasal patency could be improved. The attribute which could be improved the most was "correlation with symptom scores", with a 30% score on the points system used. The capability to "separately and simultaneously assess both nostrils" was ranked second, with 21% of the points (Figure 2 ). Overall, objective assessments were rarely used by the respondents in the diagnosis of nasal blockage, with only 19% using PNIF rate, which was the most commonly used test. The main reason given for not using them was lack of availability. The large majority of respondents felt that existing objective nasal patency assessment tools could be improved. The ability to assess both nostrils independently, with measurement of non-forced resting breathing, and improved correlation to symptom scores, were prioritised by respondents as desirable features of a potential novel nasal patency assessment tool.
Comparison with other studies
Murrell carried out a similar survey at the 2011 Rhinoplasty Society meeting in Boston, USA. 4 The results from that survey are broadly in keeping with our data. Almost all of the respondents used anterior rhinoscopy (which in this survey was part of physical examination). Objective methods were also rarely used. 4 respondents (out of a total of 49) used rhinomanometry for preoperative assessment, which was the most frequently used objective measure. Clinical history and misting patterns were not mentioned in Murrell's study, although in the case of the former, this was more likely to be due to the reasonable assumption that it would be used universally. The main difference between the two studies was the low of patient-reported outcome measure (PROMs) usage in the UK study, compared to just under two thirds of the US respondents who did use them.
Study limitations
The There are a number of objective methods capable of quantifying nasal obstruction, which are most often utilised in clinical research, and occasionally employed in clinical practice. These include acoustic rhinometry, rhinomanometry and peak nasal inspiratory flow (PNIF).
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Acoustic rhinometry is user-dependent and subject to inter-user variability. It has the ability to localise the area of obstruction within the nose, through measurement of the cross-sectional area at multiple points within the nasal cavity. It is also used to assess mucosal reversibility via pre-and post-decongestant assessment. However, it does not offer a dynamic measurement of nasal airflow and hence does not directly assess function. 6, 7 Similarly, crosssectional imaging provides excellent anatomical definition of the nose; however, it cannot provide functional information. 8, 9 Rhinomanometry provides a dynamic assessment of nasal patency, and can provide unilateral assessment. It is considered to be the gold standard in objective nasal assessment; however it is considered relatively expensive, user-dependent and time-consuming. 10 Peak nasal inspiratory flow rate (PNIF) is increasingly used in clinical practice and is a validated method of assessing nasal patency. However it is dependent on lung function;
therefore patients with pulmonary disease may provide falsely low readings. In addition, the technique is effort-dependent and therefore subject to inter-observation variability and potentially user bias. It assesses forced, inspiratory nasal breathing only, which introduces non-physiological cartilaginous collapse through the Bernoulli effect. This decreases the applicability of the result to resting nasal patency, and may explain its limited correlation with subjective symptom scores. 11 The technique is also unable to delineate the level of obstruction.
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Validated patient-reported outcome measures (PROMs) are frequently used to assess the severity of nasal disease, and to determine treatment effect. Commonly-used questionnaires are the NOSE score 12 and the Sinonasal Outcome Test (SNOT-22/23). The SNOT-22 score has been validated independently in patients undergoing both septorhinoplasty [14] [15] and endoscopic sinus surgery 16 .
The study confirms the desire among clinicians for a novel device capable of providing an objective, dynamic assessment of nasal airflow, which correlates well with the patient's subjective experience of blockage, and allows the patient and clinician to visualise and understand their pathology during resting nasal breathing. Direct real-time comparison of left versus right-sided airflow would be of great use in planning surgery for septoplasty or functional septorhinoplasty, and also for assessing post-operative outcomes in clinical practice and research. Equally, there is a growing need to improve patient education during their rhinological journey, and a further need to reassure a subgroup of patients, who may feel blocked subjectively, but in reality have patent nasal airways. These data have provided a knowledge base to guide the design of such a device, particularly bearing in mind the preference of clinicians for a simple test administration, best demonstrated by the popularity of the nasal misting pattern testing. We are also conducting a further study to investigate the end-user experience of patients in having their nasal blockage measured, aiming to find the optimal way of demonstrating the findings to the patient.
Conclusion
In the current absence of a widely-adopted objective measure of nasal airflow we would recommend the use of NIPF as well as the use of the validated NOSE and SNOT 22/23
PROMs to aid patient assessment and monitor treatment outcomes. 
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